The Commission calls on changes to the WTO patent rules, to ensure that also the poorest countries can have access to generic drugs.
The EU is making a proposal to the Trade Related Intellectual Property Rights (TRIPS) to enable poor countries without capacity of producing drugs, to get access to essential medicines. The EU is proposing a new paragraph in the TRIPS agreement, so that a foreign supplier can provide medicines on the basis of a compulsory licence issued to a developing country in order to address serious public health needs.
At the same time, the US is also planning to present a similar proposal. The content is mainly the same as the EU proposal, but the legal go-about has to be clarified.